BB Biotech 2nd Line Ord Shs (BBZA) – Aktiekurs og nyheder – Google Finans

StartBBZA • ETR

BB Biotech 2nd Line Ord Shs

42,70 €

31. jan., 13.38.40 GMT+1 · EUR · ETR · Ansvarsfraskrivelse

AktieVærdipapir børsnoteret i DEHovedkvarter i CH

Seneste lukkekurs

42,60 €

Dagsinterval

42,60 € - 43,00 €

Årsinterval

37,05 € - 52,60 €

Markedsværdi

2,23 mia. CHF

Gns. volumen

21,69 t

P/E-værdi

-

Udbytteprocent

-

Primær børs

SWX

Markedsnyheder

for 12 timer siden

Fremtiden for biotek? Mød spilændreren på Nasdaq: TNXP

for 44 minutter siden

Stock market today: Nasdaq, S&P 500, Dow set for gains as investors embrace Apple earnings

Proactive financial news

for 1 time siden

Nasdaq seen rallying before key inflation figures

for 1 time siden

ArcBest (NASDAQ:ARCB) Reports Q4 In Line With Expectations, Stock Soars

for 2 timer siden

European Stocks Set for Best Month in Two Years: Markets Wrap

for 15 timer siden

Stock Market News for Jan. 30: Dow, S&P 500, Nasdaq end higher after Trump tariff comments spark choppy trading

Om

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Grundlagt

9. nov. 1993

Hovedkvarter

Küsnacht Zürich
Schweiz

Website

Søgning

Ryd søgning

Luk søgning

Google-apps

Hovedmenu